Global research mapping of substance use disorder and treatment 1971–2017: implications for priority setting

Substance Abuse Treatment, Prevention, and Policy - 2019
Bach Xuan Tran1,2, Mackenzie Moir3,4, Carl A. Latkin5,1, Brian J. Hall5,1, Cuong Tat Nguyen6, Giang Hai Ha6, Nam Ba Nguyen4, Cyrus S. H. Ho7, Roger C. M. Ho8,9
1Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA
2Institute for Preventive Medicine and Public Health, Hanoi Medical University, Hanoi, Vietnam
3School of Public Health, University of Alberta, Alberta, Canada
4Center for Evidence-based Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam
5Global and Community Mental Health Research Group, Faculty of Social Sciences, University of Macau, Macao, People’s Republic of China
6Institute for Global Health Innovations, Duy Tan University, Da Nang, Vietnam
7Department of Psychological Medicine, National University Hospital, Singapore, Singapore
8Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
9Center for Behavioral Medicine, Nguyen Tat Thanh University, Ho Chi Minh City, Vietnam

Tóm tắt

Globally, substance use disorders are prevalent and remain an intractable public health problem for health care systems. This study aims to provide a global picture of substance use disorders research. The Web of Science platform was used to perform a cross-sectional analysis of scientific articles on substance use disorders and treatment. Characteristics of publication volume, impact, growth, authors, institutions, countries, and journals were examined using descriptive analysis and network visualization graphs. Thirteen thousand six hundred eighty-five papers related to illicit drugs (5403), tobacco (4469), and alcohol (2137) use disorders and treatment were published between 1971 and 2017. The number of publications on Mindfulness and Digital medicine topics had the highest increase with more than 300% since 2003–2007 despite later presence than other methods. The number of papers on other non-pharmaceutical therapies (behavioral therapy, cognitive behavioral therapy, skills training or motivational interviewing) grew gradually, however, the growth rate was lower every 5-year period. The United States is the substance use disorder research hub of the world with the highest volume of publications (8232 or 60.2%) and total citations (252,935 or 65.2%), number of prolific authors (25 of top 30 or 83%) and institutions (24 of top 26 or 92%), formed the most international research partnerships (with 96 distinct countries). The international collaboration followed a pattern based on geographic proximity and cultural similarity. This study offers a comprehensive picture of the global trend of publications of substance use disorder. Findings suggest a need for research policy that supports the examination of interventions that culturally adhere to different local contexts to address substance use disorder in communities.

Từ khóa


Tài liệu tham khảo

United Nations Office on Drugs and Crime V. World Drug Report 2018: Executive summary conclusions and policy implications. 2018.

WHO. World Drug Report 2018: Global overview of drug demand and supply. Latest trends, cross-cutting issues. p. 2018.

WHO. Global status report on alcohol and health 2014. Geneva; 2014.

World Health Organisation. WHO Global Report on Trends in Prevalence of Tobacco Smoking 2000-2025. Second edition. Geneva: World Health Organisation; 2018.

Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet (London, England). 2013;382:1575–86 Elsevier.

Degenhardt L, Whiteford HA, Ferrari AJ, Baxter AJ, Charlson FJ, Hall WD, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the global burden of disease study 2010. Lancet. 2013;382:1564–74.

Murray CJL, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2197–223 Elsevier.

WHO. Disease burden and mortality estimates: Cause-Specific Mortality, 2000–2016 [Internet]. 2018. Available from: http://www.who.int/healthinfo/global_burden_disease/GHE2016_Deaths_Global_2000_2016.xls?ua=1

Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1260–344 Elsevier.

Jain R, Majumder P, Gupta T. Pharmacological intervention of nicotine dependence. Biomed Res Int. 2013;2013:–278392.

Schmelzle J, Rosser WW, Birtwhistle R. Update on pharmacologic and nonpharmacologic therapies for smoking cessation. Can Fam Phys Med De Famille Canadien. 2008;54:994–9.

Heydari G, Masjedi M, Ahmady AE, Leischow SJ, Lando HA, Shadmehr MB, et al. A comparative study on tobacco cessation methods: a quantitative systematic review. Int J Prev Med. 2014;5:673–8.

Jiloha RC. Non-Pharmacological Treatment of Alcohol Dependence. Delhi Psychiatry J. 2007;10:119–22.

Lu L, Liu Y, Zhu W, Shi J, Liu Y, Ling W, et al. Traditional medicine in the treatment of drug addiction. Am J Drug Alcohol Abuse. 2009;35:1–11.

WHO. Global strategy to reduce the harmful use of alcohol. 2010;

United Nations Office on Drugs and Crime (UNODC). International Standards for the Treatment of Drug Use Disorders. 2017.

WHO. WHO Report on the Global Tobacco Epidemic, 2015: Raising taxes on tobacco. 2015.

WHO. Who report on the global tobacco epidemic, 2017: Monitoring tobacco use and prevention policies. 2017.

Wiessing L, Ferri M, Běláčková V, Carrieri P, Friedman SR, Folch C, et al. Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm Reduct J. 2017;14:19.

Baingana F, al’Absi M, Becker AE, Pringle B. Global research challenges and opportunities for mental health and substance-use disorders. Nature. 2015;527:S172–7.

Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105:1809–31 Springer.

Sweileh WM, Zyoud SH, Al-Jabi SW, Sawalha AF. Substance use disorders in Arab countries: research activity and bibliometric analysis. Subst Abuse Treat Prev Policy 2014 [cited 2019 Feb 6];9. Available from: https://substanceabusepolicy.biomedcentral.com/articles/10.1186/1747-597X-9-33.

Zyoud SH, Waring WS, Al-Jabi SW, Sweileh WM. Global cocaine intoxication research trends during 1975–2015: a bibliometric analysis of web of science publications. Subst Abuse Treat Prev Policy 2017 [cited 2019 Feb 6];12. Available from: http://substanceabusepolicy.biomedcentral.com/articles/10.1186/s13011-017-0090-9.

Valderrama-Zurián JC, Melero-Fuentes D, Aleixandre-Benavent R. Bibliographic searches for a bibliometric analysis on drug addiction. Eur Addict Res. 2015;21:31–2.

Khalili M, Rahimi-Movaghar A, Shadloo B, Mojtabai R, Mann K, Amin-Esmaeili M. Global scientific production on illicit drug addiction: a two-decade analysis. Eur Addict Res. 2018;24:60–70.

Tadmouri GO, Bissar-Tadmouri N. A major pitfall in the search strategy on PubMed. Saudi Med J. 2004;25:7–10.

Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, web of science, and Google scholar: strengths and weaknesses. FASEB J. 2008;22:338–42.

Kulkarni AV, Aziz B, Shams I, Busse JW. Comparisons of citations in web of science, Scopus, and Google scholar for articles published in general medical journals. JAMA. 2009;302:1092–6.

Substance Abuse and Mental Health Services Administration. Substance use disorders. [internet]. [cited 2018 Aug 24]. Available from: https://www.samhsa.gov/disorders/substance-use

Aos S, Jim M, Miller M, Yan W. Evidence-based treatment of alcohol, drug, and mental health disorders: potential benefits, costs, and fiscal impacts for Washington state. Olympia; 2006.

Das JK, Salam RA, Arshad A, Finkelstein Y, Bhutta ZA. Interventions for adolescent substance Abuse: an Overview of systematic reviews. The. J Adolesc Health. 2016;59:S61–75 Elsevier.

Carney T, Myers B. Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2012;7:25.

Li W, Howard MO, Garland EL, McGovern P, Lazar M. Mindfulness treatment for substance misuse: a systematic review and meta-analysis. J Subst Abus Treat. 2017;75:62–96.

Opthof T, Wilde AAM. The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: the case of Dutch professors in clinical cardiology. Netherlands Heart J. 2009;17:145–54.

Kissin I. Scientometric assessment of drugs for chronic pain, 1979–2013: rapid growth of publications, paucity of successful drugs. J Pain Res. 2014;7:505 Dove Press.

Van Eck NJ, Waltman L. Text mining and visualization using VOSviewer. ISSI Newsletter:50–4.

van Eck NJ, Waltman L. Visualizing bibliometric networks. In: Ding Y, Rousseau R, Wolfram D, editors. Measuring scholarly impact: methods and practice [internet]. Cham: Springer International Publishing; 2014. p. 285–320. Available from: https://doi.org/10.1007/978-3-319-10377-8_13.

Shi J, Peng Y, Fantinato M, Chen J. A study on the author collaboration network in big data; 2017.

Uchtenhagen A. Substance use problems in developing countries. Bull World Health Organ. 2004:639–718.

Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70:516–27.

Hall SM, Reus VI, Munoz RF, Sees KL, Humfleet G, Hartz DT, et al. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 1998;55:683–90.

Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement therapy for smoking cessation. The Cochrane database of systematic reviews; 2008. p. Cd000146.

Zgierska A, Rabago D, Zuelsdorff M, Coe C, Miller M, Fleming M. Mindfulness meditation for alcohol relapse prevention: a feasibility pilot study. J Addict Med. 2008;2:165–73.

Witkiewitz K, Bowen S, Harrop EN, Douglas H, Enkema M, Sedgwick C. Mindfulness-based treatment to prevent addictive behavior relapse: theoretical models and hypothesized mechanisms of change. Subst Use Misuse. 2014;49:513–24.

Muench F. The promises and pitfalls of digital Technology in its Application to alcohol treatment. Alcohol Res. 2014;36:131–42.

Woolley R, Robinson-Garcia N, Costas R. Global research collaboration: networks and partners in South East Asia; 2017.

Chen K, Yao Q, Sun J, He Z, Yao L, Liu Z. International publication trends and collaboration performance of China in healthcare science and services research. Israel J Health Policy Res. 2016;5:1.

Lincoln M. Alcohol and drinking cultures in Vietnam: a review. Drug Alcohol Depend. 2016;159:1–8.

Thông tin
Thông tin xuất bản

Substance Abuse Treatment, Prevention, and Policy

Thông tin tác giả